Zimbabwe has rejected a major American health deal valued at $367m (272 million pounds) over five years over Washington's insistence on confidential information.
This move came to light after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".
An official spokesperson has since stated that the United States was requesting health data for research and commercial purposes while was not willing to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for continued talks to reach a agreement suitable to all parties so the country's vital HIV programme can proceed.
Broader Implications
This development comes after a similar case in neighbouring Kenya, where a high court halted a similar health funding agreement following legal challenges were raised about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and responsibility.
According to statements, 16 nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in new funding.
Details of the Declined Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for medical research with no certainty that the final treatments would be available to our citizens should a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were upending frameworks already established through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a nation provides its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued discussions with our American counterparts on how future co-operation could be arranged in a manner that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but recommended that talks need to persist considering a large portion of the country's HIV programmes depended on foreign aid.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," the group said.
The situation emphasises the complex challenges between accepting much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.